403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Briacell Therapeutics Corp.
(MENAFN- Baystreet) 10:40 AM EST - BriaCell Therapeutics Corp. : Today announced the publication of the mechanism of action of its next generation personalized off-the-shelf immunotherapy. This research conducted in collaboration with the National Cancer Institute (NCI), the US federal government's principal agency for cancer research and training, has been published at JCI Insight, a highly rated peer-reviewed journal dedicated to advancing biomedical research from preclinical discovery through to clinical development. BriaCell Therapeutics Corp.
shares T are trading up $0.89 at $11.10.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment